Turner White CommunicationsAbout TWCSubscribeContact TWCHomeSearch
Hospital PhysicianJCOMSMPBRMsCart
Current Contents
Where We Are Indexed
Past Issue Archives
Clinical Communication
CME
Outcomes
Research
In Review
Editorial Board
Information for Authors
Author Form

Reprints, Permissions, & Copyright
Site Map
 
JCOM
BACK ISSUE articles are $15 each.
 
International credit cards NOT accepted.



JCOM Paid Subscribers
LOG IN
user name:
password:
 
Forgot password?

JCOM Abstract


J Clin Outcomes Manage 
2000 Jul;7(7):23-26
Use of RSV-IGIV: one hospital's experience
Lee KR, Teter BW, Margolis KA, DeVincenzo JP, Barrett FF

Respiratory syncytial virus immune globulin intravenous (RSV-IGIV) is approved for prevention of RSV disease in children younger than 24 months with bronchopulmonary dysplasia or premature birth. The authors report on compliance and other outcomes in patients receiving this drug during 2 RSV seasons.

Original research

Search the Turner White index to find abstracts of articles published in JCOM.





New issues are posted one month following publication of the printed journal.



View past issue archives:    2013    2012    2011    2010    2009    2008    2007
   2006    2005    2004    2003     2002     2001     2000     1999



Hospital Physician     JCOM     Seminars in Medical Practice
Hospital Physician Board Review Manuals
About TWC    Subscribe    Contact TWC    Home    Search   Site Map

Copyright © 2014, Turner White Communications
Updated 1/20/14 • jdw